author-photo

Arabella B. Tilden

University of Alabama at Birmingham

50

Papers

2006

Citations

Citation Trend

Filter By

Papers (50) Sort By

Journal Conference Others

In Vivo T Cell Depletion With Dexamethasone Reduces Graft Versus Host Disease (GVHD) With Minimal Side Effects and No Additional Risk of Early Relapse After Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation

2011 Biology of Blood and Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (1)
B cells correlates with their ability to produce interleukin 1 Expression of myelomonocytic antigens on chronic lymphocytic leukemia

2011
Show All
- Source
- Cite
- Save
Citations (0)
Standardization of T Cell (CD3+) Dose for Allogeneic Peripheral Blood Stem Cell Grafts

2009 Biology of Blood and Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (0)
ASBMT Risk Group and CD 34+ Dose Predicted for the Development of aGVHD in Allogeneic MRD Transplants When the Donors Who Received a Combined Mobilization and In Vivo TCD Regimen Using rhg-CFS and Dexamethasone.

2007 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Use of Dexamethasone Given to Sibling Donors as a Way of In Vivo Purging of Allo Reactive Donor T Cells in rhg-CSF Mobilized Peripheral Blood Stem Cell Transplantations Resulted in Significant Decrease in CD3+ Cells and Increased CD34+ Yield.

2007 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Improved Outcomes in Intermediate- and High-Risk Aggressive Non-Hodgkin Lymphoma after Autologous Hematopoietic Stem Cell Transplantation Substituting Intravenous for Oral Busulfan in a Busulfan, Cyclophosphamide, and Etoposide Preparative Regimen

2006 Biology of Blood and Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (43)
Reduction in serum myeloma (M) paraprotein after cyclophosphamide (Cy) mobilization predicts for improved survival after single-agent melphalan (MEL)–based autologous hematopoietic stem cell transplantation (AHSCT)

2005 Biology of Blood and Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (0)
A phase I-II trial to examine the toxicity of CMV-and EBV-specific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34-selected/T cell-depleted stem cell transplants

2000 Human Gene Therapy
Show All
- Source
- Cite
- Save
Citations (45)
Chimeric Antibodies with Specificity for Tumor Antigens: Demonstration of in Situ Localization to Tumors after Antibody Therapy

1998 Biotechnic & Histochemistry
Show All
- Source
- Cite
- Save
Citations (2)
A novel gene therapy strategy for elimination of prostate carcinoma cells from human bone marrow.

1997 Human Gene Therapy
Show All
- Source
- Cite
- Save
Citations (29)